We observed that CD45+ immune cells mainly gathered at the edge of the tumor, while the immune infiltration in the center of the tumor was very low, which was similar to the tumor immune cell infiltration in clinical patients (Figure 3D). The gene discussed is PTPRC; the disease is neoplasm.